APLLTD Neutral to bullish
Alembic Pharma gets EIR from USFDA for Karakhadi facility
The US regulator has also indicated that a compliance verification would be performed during re-inspection of the said facility in the next review cycle, it added.
The US regulator has also indicated that a compliance verification would be performed during re-inspection of the said facility in the next review cycle, it added.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.